A Journal of the American College of Cardiology study this week linked long-term alcohol consumption to adverse cardiac remodeling in patients who were initially young and healthy—something the paper’s authors said might be offset by drinking predominantly wine.

Half of patients who receive percutaneous coronary intervention (PCI) at Veterans Affairs (VA) hospitals in the U.S. travel more than 48 miles for the procedure; a quarter travel at least 110 miles. Yet distance to the PCI site doesn’t significantly influence one-year outcomes, a recent study found.

The FDA has approved Contego Medical’s Paladain Carotid PTA Balloon System, the first approved embolic protection device to contain both a carotid angioplasty balloon and an integrated filter.

ST-segment elevation myocardial infarction (STEMI) patients have better odds of survival if emergency medical services (EMS) personnel alert the hospital where the patient will be arriving ahead of time, according to a study published Sept. 17 in JACC: Cardiovascular Interventions.

Heart failure patients who are discharged from the hospital before they reach euvolemia—a healthy balance of blood in the body—are more likely to be readmitted in both the short- and long-term, according to research published in the American Journal of Cardiology this month.

A daily, low dose of aspirin isn’t preventive against early death or disability in older patients who are otherwise healthy, according to results from the eight-year ASPREE trial that were released Sept. 16.

Dual-energy (DE) CT iodine maps offer a slight benefit when paired with traditional CT angiography images in diagnosing pulmonary embolism (PE), reported researchers in a Sept. 11 Radiology study.

The European Medicines Agency (EMA) and the FDA said late last week a second toxin that may cause cancer has been detected in valsartan—a common heart drug that has already been recalled in about two dozen countries due to the presence of N-nitrosodimethylamine (NDMA), a probable human carcinogen.